Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 2 33-2, 2005, Pages

  Zhu, Bing ^a   Strada, Samuel ^a   Stevens, Troy ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Atrial natriuretic peptide; Cell proliferation; Guanosine 3 ,5 cyclic monophosphate; Pulmonary endothelium; Vascular endothelial growth factor

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; ATRIAL NATRIURETIC FACTOR; COMPLEMENTARY DNA; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE 5; GUANYLATE CYCLASE; INDOLIDAN; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; UNCLASSIFIED DRUG; VASCULOTROPIN; VINPOCETINE; ZAPRINAST;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; LUNG BLOOD VESSEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GUANYLATE CYCLASE; IMMUNOPRECIPITATION; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PULMONARY ALVEOLI; PULMONARY ARTERY; PURINONES; RATS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 22444447950     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00433.2004     Document Type: Article

References (45)

1. Baertschi AJ and Teague WG. Alveolar hypoxia is a powerful stimulus for ANF release in conscious lambs. Am J Physiol Heart Circ Physiol 256: H990-H998, 1989.
2. Buchan KW and Martin W. Modulation of agonist-induced calcium mobilization in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cGMP. Br J Pharmacol 104: 361-366, 1991.
3. Burns F, Rodger IW, and Pyne NJ. The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung. Biochem J 283: 487-491, 1992.
4. Cahill PA and Hassid A. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors. J Cell Physiol 154: 28-38, 1993.
5. Cioffi DL, Moore TM, Schaack J, Creighton JR, Cooper DM, and Stevens T. Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase. J Cell Biol 157: 1267-1278, 2002.
6. DeMello DE, Sawyer D, Galvin A, and Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 16: 568-581, 1997.
7. DeMello DE and Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr Dev Pathol 3: 439-449, 2000.
8. Gebb S and Stevens T. On lung endothelial cell heterogeneity. Microvasc Res 68: 1-12, 2004.
9. Guh JH, Hwang TL, Ko FN, Chueh SC, Lai MK, and Teng CM. Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor. Mol Pharmacol 53: 467-474, 1998.
10. Han P, Zhu X, and Michaeli T. Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem 272: 16152-16157, 1997.
11. Ikeda E, Achen MG, Breier G, and Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766, 1995.
12. Itoh H, Pratt RE, Ohno M, and Dzau VJ. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19: 758-761, 1992.
13. Itoh H, Pratt RE, and Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86: 1690-1697, 1990.
14. 2+ and permeability. Am J Physiol Lung Cell Mol Physiol 274: L810-L819, 1998.
15. King J, Hamil T, Creighton J, Wu S, Bhat P, McDonald F, and Stevens T. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 67: 139-51, 2004.
16. Kotera J, Fujishige K, Akatsuka H, Imai Y, Yanaka N, and Omori K. Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase. J Biol Chem 273: 26982-26990, 1998.
17. Li H, Liu L, David ML, Whitehead CM, Chen M, Fetter JR, Sperl GJ, Pamukcu R, and Thompson WJ. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation. Biochem Pharmacol 64: 1325-1336, 2002.
18. Liu L, Underwood T, Li H, Pamukcu R, and Thompson WJ. Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase. Cell Signal 14: 45-51, 2002.
19. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, and Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-413, 2000.
20. 2+ and inositol polyphosphates. Am J Physiol Lung Cell Mol Physiol 263: L219-L225, 1992.
21. Mazurier C, Ribba AS, Gaucher C, and Meyer D. Molecular genetics of von Willebrand disease. Ann Genet 41: 34-43, 1998.
22. McKenzie JC, Tanaka I, Inagami T, Misono KS, and Klein RM. Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc Soc Exp Biol Med 181: 459-463, 1986.
23. 2-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells. Cancer Res 62: 5711-5719, 2002.
24. Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, and Matsuda Y. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun 176: 949-957, 1991.
25. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, and Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581, 1995.
26. Netherton SJ and Maurice DH. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol Pharmacol 67: 263-272, 2005.
27. Pandey KN, Nguyen HT, Li M, and Boyle JW. Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem Biophys Res Commun 271: 374-379, 2000.
28. Pedram A, Razandi M, Hu RM, and Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 272: 17097-17103, 1997.
29. Pedram A, Razandi M, and Levin ER. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 142: 1578-1586, 2001.
30. Porter JG, Catalano R, McEnroe G, Lewicki JA, and Protter AA. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol Cell Physiol 263: C1001-C1006, 1992.
31. Sharma GD, Nguyen HT, Antonov AS, Gerrity RG, von Geldern T, and Pandey KN. Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and p38MAPK) in cultured human vascular smooth muscle cells. Mol Cell Biochem 233: 165-173, 2002.
32. 2-terminal kinase 1. Clin Cancer Res 6: 4136-4141, 2000.
33. Soh JW, Mao Y, Liu L, Thompson WJ, Pamukcu R, and Weinstein IB. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J Biol Chem 276: 16406-16410, 2001.
34. Souness JE, Brazdil R, Diocee BK, and Jordan R. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methyl-amino)xanthine. Br J Pharmacol 98: 725-734, 1989.
35. Stevens T, Creighton J, and Thompson WJ. Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function. Am J Physiol Lung Cell Mol Physiol 277: L119-L126, 1999.
36. 2+ and adenylyl cyclase responses in phenotypically distinct pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 272: L51-L59, 1997.
37. 2+-inhibitable adenylyl cyclase modulates pulmonary artery endothelial cell cAMP content and barrier function. Proc Natl Acad Sci USA 92: 2696-2700, 1995.
38. Thompson WJ, Piazza GA, Li H, Liu L, Fetter J, Zhu B, Sperl G, Ahnen D, and Pamukcu R. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin. Cancer Res 60: 3338-3342, 2000.
39. Thompson WJ, Terasaki WL, Epstein PM, and Strada SJ. Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv Cyclic Nucleotide Res 10: 69-92, 1979.
40. Thompson WJ, Ashikaga T, Kelly JJ, Liu L, Zhu B, Vemavarapu L, and Strada SJ. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). Biochem Pharmacol 63: 797-807, 2002.
41. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, Edwards WD, Schaff HV, and Burnett JC. Natriuretic peptide system in human heart failure. Circulation 88: 1004-1009, 1993.
42. Wu CF, Bishopric NH, and Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 272: 14860-14866, 1997.
43. Yoon JT, Palazzo AF, Xiao D, Delohery TM, Warburton PE, Bruce JN, Thompson WJ, Sperl G, Whitehead C, Fetter J, Pamukcu R, Gundersen GG, and Weinstein IB. CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells. Mol Cancer Ther 1: 393-404, 2002.
44. Zhu B, Kelly J, Vemavarapu L, Thompson WJ, and Strada SJ. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells. Biochem Pharmacol 68: 479-491, 2004.
45. Zhu B, Vemavarapu L, Thompson WJ, and Strada SJ. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells. J Cell Biochem 94: 336-350, 2005.